“…[3,6,11,22,23,43,49] In these models, a variety of drugs that block the effects of glutamate both presynaptically and at postsynaptic receptor sites have reduced both ischemic brain damage and glutamate release. [5,7,12,20,21,24,25,29,32,33,36,40,53,55,56] There are now several Phase II and Phase III trials in progress to evaluate the efficacy of glutamate antagonist drugs in both neurotrauma and stroke.…”